(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS TGM2 (TRANSGLUTAMINASE 2, TRANSGLUTAMINASE-2 (TG2), PROTEINGLUTAMINE- GAMMA-GLUTAMYLTRANSFERASE C POLYPEPTIDE, TGC)], HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN (1-441) [HUMANIZED VH (HOMO SAPIENS IGHV3-23*03 (89.8%) -(IGHD) -IGHJ4*01 (100%)) [8.8.7] (1-114) -HOMO SAPIENS IGHG4*01 (CH1 (115-212), HINGE S10>P (222) (213-224), CH2 (225-334), CH3 (335- 439), CHS (440-441)) (115-441)], (128-214')-DISULFIDE WITH KAPPA LIGHT CHAIN CHIMERIC (1'-214') [V-KAPPA (MUS MUCULUS IGKV14-111*01 (82.1%)/HOMO SAPIENS IGKV1- 16*01 (78.9%) -HOMO SAPIENS IGKJ1*01 (91.7%)) [6.3.9] (1'-107') -HOMO SAPIENS IGKC*01, KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (220-220":223-223")-BISDISULFIDE. PROPOSED INN: LIST 119(WHO)
ZAMPILIMABUM(INN)